Warren, R., Reich, K., Simpson, E., Langley, R., Costanzo, A. ., Saeki, H., Almgren, P., Vacko, E., Carlsson, A., Gooderham, M., Deleuran, M., Silvestre, J. F., Weidinger, S. and Blauvelt, A. (2023) “3 years of tralokinumab treatment provides long term disease control as demonstrated by clinically meaningful outcomes in modera te to severe atopic dermatitis”, SKIN The Journal of Cutaneous Medicine, 7(2), p. s142. doi: 10.25251/skin.7.supp.142.